Tellimer

TH : PTT - Entering the life science business

PTT plans to diversify to the pharmaceutical, nutrition and medical supply businesses given their higher EPS growth potential vs. oil gas business. In the medium term, the initial investment sizes, risks and return should remain small compared to those of existing businesses, in our view.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers